Alkermes Plc (ALKS)
Alkermes Market Cap: 5.654B for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Avadel Pharmaceuticals Plc | 2.103B |
| CorMedix, Inc. | 589.34M |
| Amicus Therapeutics, Inc. | 4.407B |
| Jazz Pharmaceuticals Plc | 10.39B |
| Amarin Corp. Plc | 335.39M |
Market Cap Related Metrics
| PE Ratio | 16.94 |
| PS Ratio | 3.782 |
| PEG Ratio | 5.744 |
| Price to Book Value | 3.262 |
| Price to Free Cash Flow | 11.72 |
| Price | 34.24 |
| Earnings Yield | 5.90% |
| PEGY Ratio | 5.744 |
| Operating PE Ratio | 16.05 |
| Normalized PE Ratio | 16.91 |